You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020145014
Dec 20201202
Jan 20212301
Feb 202121012
Mar 202152014
Apr 202182016
May 2021603
Jun 2021009
Jul 20210010
Aug 2021007
Sep 2021005
Oct 202146026
Nov 202126015
Dec 20213205
Jan 20221801
Feb 202248011
Mar 20223005
Apr 202276015
May 20223203
Jun 20221807
Jul 20222401
Aug 20223202
Sep 20223203
Oct 20223001
Nov 2022801
Dec 20222602
Jan 20235202
Feb 20233002
Mar 20231002
Apr 20231600
May 20231004
Jun 20231200
Jul 20231402
Aug 2023600
Sep 20231202
Oct 20234605
Nov 20233402
Dec 20234601
Jan 20245801
Feb 20242001
Mar 20241204
Apr 20242202
May 20242201
Jun 20241801
Jul 20242801
Aug 20241403
Sep 20242201
Oct 20242006
Nov 2024704
Dec 20241407
Jan 202518010
Feb 2025805
Mar 20250013
Apr 2025002
May 2025007
Jun 2025004
Total13900286